MASH
Clinical trials for MASH explained in plain language.
Never miss a new study
Get alerted when new MASH trials appear
Sign up with your email to follow new studies for MASH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New MASH drug enters human testing – first safety check underway
Disease control OngoingThis early-stage study tests a new drug called CS060304 in healthy volunteers and people with high LDL-C (bad cholesterol) to see if it is safe and how the body processes it. The drug is being developed for MASH, a serious liver disease. About 80 participants will receive either …
Matched conditions: MASH
Phase: PHASE1 • Sponsor: Cascade Pharmaceuticals, Inc • Aim: Disease control
Last updated May 26, 2026 05:07 UTC
-
New drug trial targets advanced MASH liver damage
Disease control OngoingThis early-stage study tests a new medicine called RO7790121 in 50 adults with advanced liver scarring (fibrosis) caused by MASH. The main goal is to check the drug's safety and how the body processes it. Participants must have a certain body mass index and liver stiffness level.…
Matched conditions: MASH
Phase: PHASE1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 14, 2026 12:02 UTC